- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Context Therapeutics Inc (CNTX)
Assess today's live Context Therapeutics Inc (CNTX) share price, performance and insights using our live NASDAQ: CNTX stock exchange data.
Analyse the historical data and Context Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Context Therapeutics share price buy/sell indicators using real-time data (or discuss the Context Therapeutics (CNTX) stock price today with other investors in the Context Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CNTX share price (ISIN: US21077P1084) to enhance your trading decisions with our free investment tools and resources.
What Is the Context Therapeutics Inc Share Price Today?
The Context Therapeutics share price today is 1.110.
What Is the Stock Symbol for Context Therapeutics Inc
The stock symbol (or 'ticker') for Context Therapeutics Inc is "CNTX."
What Stock Exchange Does Context Therapeutics Inc Trade On?
Context Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Context Therapeutics Inc a Good Stock to Buy?
Determining whether Context Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Context Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Context Therapeutics share price buy/sell indicators using real-time data (or discuss the Context Therapeutics (CNTX) stock price today with other investors in the Context Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CNTX share price (ISIN: US21077P1084) to enhance your trading decisions with our free investment tools and resources.
What Is the Context Therapeutics Inc Share Price Today?
The Context Therapeutics share price today is 1.110.
What Is the Stock Symbol for Context Therapeutics Inc
The stock symbol (or 'ticker') for Context Therapeutics Inc is "CNTX."
What Stock Exchange Does Context Therapeutics Inc Trade On?
Context Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Context Therapeutics Inc a Good Stock to Buy?
Determining whether Context Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.075
1.270
52 wk Range
0.490
1.550
CNTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.0751.270
52 wk Range
0.4901.550
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CNTX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
5.571
Upside
+401.93%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Context Therapeutics Company Profile
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Compare CNTX to Peers and Sector
Metrics to compare | CNTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCNTXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.9x | −1.9x | −0.6x | |
PEG Ratio | −0.06 | −0.08 | 0.00 | |
Price/Book | 1.4x | 2.4x | 2.6x | |
Price / LTM Sales | - | 5.4x | 3.2x | |
Upside (Analyst Target) | 350.5% | 81.3% | 41.8% | |
Fair Value Upside | Unlock | 23.4% | 5.1% | Unlock |
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 5.571
(+401.93% Upside)
Earnings
Latest Release
Nov 06, 2025
EPS / Forecast
-0.10 / -0.09
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Context Therapeutics (CNTX) Share Price Today?
The live Context Therapeutics share price today is 1.110
What Stock Exchange Does Context Therapeutics (CNTX) Trade On?
Context Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Context Therapeutics?
The stock symbol (also called a 'ticker') for Context Therapeutics is "CNTX."
What Is the Current Context Therapeutics Market Cap?
As of today, Context Therapeutics market capitalisation is 101.99M.
What Is Context Therapeutics's (CNTX) Earnings Per Share (TTM)?
The Context Therapeutics EPS is currently -0.29 (Trailing Twelve Months).
When Is the Next Context Therapeutics Earnings Date?
Context Therapeutics's next earnings report will be released on 25 Mar 2026.
Is CNTX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Context Therapeutics moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Context Therapeutics Stock Split?
Context Therapeutics has split 0 times. (See the CNTX stock split history page for full effective split date and price information.)
How Many Employees Does Context Therapeutics Have?
Context Therapeutics has 12 employees.
What is the current trading status of Context Therapeutics (CNTX)?
As of 24 Dec 2025, Context Therapeutics (CNTX) is trading at a price of 1.110, with a previous close of 1.110. The stock has fluctuated within a day range of 1.075 to 1.270, while its 52-week range spans from 0.490 to 1.550.
What Is Context Therapeutics (CNTX) Price Target According to Analysts?
The average 12-month price target for Context Therapeutics is USD5.57143, with a high estimate of USD9 and a low estimate of USD4. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +401.93% Upside potential.
What Is the CNTX After Hours Price?
CNTX's last after hours stock price is 1.128, the stock has decreased by 0.018, or 1.630%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.